NaviFUS Corp.
TWO: 6872.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Arthur Lung
- Headquarters
- Taipei, Taiwan
- IPO year
- 2022
- Market cap
- NT$1.3B
- Website
- https://navifus.com
Loading 6872…
Loading profile data…Frequently asked questions about 6872
What does NaviFUS Corp. (6872.TWO) do?
NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug d...
Where does 6872.TWO trade?
NaviFUS Corp. (6872.TWO) trades on the Taipei Exchange.
What sector is 6872.TWO in?
NaviFUS Corp. (6872.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NaviFUS Corp.?
Arthur Lung is the chief executive officer of NaviFUS Corp. (6872.TWO).
Where is NaviFUS Corp. headquartered?
NaviFUS Corp. is headquartered in Taiwan.
Does 6872.TWO pay a dividend?
NaviFUS Corp. (6872.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6872.TWO go public?
NaviFUS Corp. (6872.TWO) completed its initial public offering in 2022.